Lysarc & Veeva: Overcoming End-to-End RTSM Challenges in a Complex Phase 3 Oncology Trial

23 October 2025

9:00 am ET / 3:00 pm CET

This webinar will highlight the successful partnership between Veeva and Lysarc, focusing on the MorningLyte study: an international Phase 3 oncology trial for Lymphoma and solving the complex RTSM challenges along the way.

Agenda Overview

  • Introduction:
    A brief overview of the Veeva-Lysarc partnership.
  • Interview and Discussion:
    A moderated discussion with our speakers on the MorningLyte study.
  • Q&A and Wrap-Up:
    Live questions from the audience followed by a summary.

Webinar Speakers

Headshot 1

Moderator:

Natalie Townsend

Vice President of Strategy
Veeva RTSM

Headshot 2

Guest Speaker:

Jérôme Paget

Head of Data Management
Lysarc

Headshot 3

Guest Speaker:

Hrvoje Evic

Senior Consultant
Veeva RTSM